## Abstract In this study, the longβterm (>3 years) efficacy of combination therapy for hepatitis B virus (HBV) recurrence and the associated factors were investigated. One hundred and sixtyβfive consecutive HBsAgβpositive patients (92 with liver cirrhosis, 73 with hepatocellular carcinoma; HCC) wh
Case Report: Effectiveness of Lamivudine in Treatment of Acute Recurrent Hepatitis B After Liver Transplantation
β Scribed by J. Ignacio Herrero; Jorge Quiroga; Bruno Sangro; Iosu Sola; Jose Ignacio Riezu-Boj; Fernando Pardo; Jesus Prieto
- Book ID
- 110378792
- Publisher
- Springer US
- Year
- 1998
- Tongue
- English
- Weight
- 423 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0163-2116
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The aim of our study was to determine the outcomes of liver transplant recipients receiving either lamivudine (LAM) monotherapy or LAM combined with low-dose intramuscular (IM) hepatitis B Immunoglobulin (HBIG) therapy. We performed a retrospective review of the medical records of patients that had
This study aimed to investigate the factors associated with viral breakthrough among liver transplant recipients who receive lamivudine monoprophylaxis. Consecutive patients receiving liver transplantation for HBV-related liver disease from June 1999 to October 2000 were studied. All patients receiv